Dow Jones U.S. Pharmaceuticals Index
D.J. US Pharmaceutical Top 10: Value Investment Strategy
TOP Value Investment Strategy
VALUEVVV
GROWTHVV
SAFETYVV
COMBINED
1. Phibro Animal (L, US) ☀
Pharmaceuticals
1. Phibro Animal (L, US) ☀
Pharmaceuticals
100
29
90
98
2. Pfizer (XXL, US) ☀
Pharmaceuticals
2. Pfizer (XXL, US) ☀
Pharmaceuticals
97
35
72
91
3. Assertio Therapeutics (S, US) Pharmaceuticals
3. Assertio Therapeutics (S, US) Pharmaceuticals
95
77
25
89
4. Bristol-Myers Squibb (XXL, US) ☀
Pharmaceuticals
4. Bristol-Myers Squibb (XXL, US) ☀
Pharmaceuticals
83
61
27
71
5. Catalent (XL, US) Pharmaceuticals
5. Catalent (XL, US) Pharmaceuticals
57
21
81
45
6. Merck & Co. (XXL, US) ☀
Pharmaceuticals
6. Merck & Co. (XXL, US) ☀
Pharmaceuticals
57
53
47
38
7. Heska (S, US) Health Care Equipment
7. Heska (S, US) Health Care Equipment
57
15
66
36
December 8, 2022. Top 10s are published weekly by Top 10 schedule . (Free Stock Update )
D.J. US Pharmaceutical Top 10: Growth Investment Strategy
TOP 10 Growth Investment Strategy
VALUEVVV
GROWTHVV
SAFETYVV
COMBINED
1. Amphastar (M, US) Pharmaceuticals
1. Amphastar (M, US) Pharmaceuticals
27
93
93
93
2. Assertio Therapeutics (S, US) Pharmaceuticals
2. Assertio Therapeutics (S, US) Pharmaceuticals
95
25
25
89
3. Zoetis (XL, US) ☀
Pharmaceuticals
3. Zoetis (XL, US) ☀
Pharmaceuticals
25
23
23
14
4. Supernus Pharma (M, US) ☀
Pharmaceuticals
4. Supernus Pharma (M, US) ☀
Pharmaceuticals
13
42
42
18
5. Bristol-Myers Squibb (XXL, US) ☀
Pharmaceuticals
5. Bristol-Myers Squibb (XXL, US) ☀
Pharmaceuticals
83
27
27
71
6. Johnson & Johnson (XXL, US) ☀
Pharmaceuticals
6. Johnson & Johnson (XXL, US) ☀
Pharmaceuticals
35
69
69
58
7. Prestige (L, US) Pharmaceuticals
7. Prestige (L, US) Pharmaceuticals
47
34
34
42
8. Eli Lilly (XXL, US) ☀
Pharmaceuticals
8. Eli Lilly (XXL, US) ☀
Pharmaceuticals
23
16
16
6
9. Merck & Co. (XXL, US) ☀
Pharmaceuticals
9. Merck & Co. (XXL, US) ☀
Pharmaceuticals
57
47
47
38
10. Nektar (S, US) Pharmaceuticals
10. Nektar (S, US) Pharmaceuticals
27
89
89
70
December 8, 2022. Top 10s are published weekly by Top 10 schedule . (Free Stock Update )
D.J. US Pharmaceutical Top 10: Safety Investment Strategy
TOP 10 Safety Investment Strategy
VALUEVVV
GROWTHVV
SAFETYVV
COMBINED
1. Amphastar (M, US) Pharmaceuticals
1. Amphastar (M, US) Pharmaceuticals
27
93
93
93
2. Phibro Animal (L, US) ☀
Pharmaceuticals
2. Phibro Animal (L, US) ☀
Pharmaceuticals
100
29
90
98
3. Nektar (S, US) Pharmaceuticals
3. Nektar (S, US) Pharmaceuticals
27
51
89
70
4. Catalent (XL, US) Pharmaceuticals
4. Catalent (XL, US) Pharmaceuticals
57
21
81
45
5. Pfizer (XXL, US) ☀
Pharmaceuticals
5. Pfizer (XXL, US) ☀
Pharmaceuticals
97
35
72
91
6. Johnson & Johnson (XXL, US) ☀
Pharmaceuticals
6. Johnson & Johnson (XXL, US) ☀
Pharmaceuticals
35
59
69
58
7. Heska (S, US) Health Care Equipment
7. Heska (S, US) Health Care Equipment
57
15
66
36
8. Pacira BioSciences (M, US) Pharmaceuticals
8. Pacira BioSciences (M, US) Pharmaceuticals
33
47
55
35
December 8, 2022. Top 10s are published weekly by Top 10 schedule . (Free Stock Update )
D.J. US Pharmaceutical Top 10: Combined Investment Strategy
TOP 10 Combined Investment Strategy
VALUEVVV
GROWTHVV
SAFETYVV
COMBINED
1. Phibro Animal (L, US) ☀
Pharmaceuticals
1. Phibro Animal (L, US) ☀
Pharmaceuticals
100
29
90
98
2. Amphastar (M, US) Pharmaceuticals
2. Amphastar (M, US) Pharmaceuticals
27
93
93
93
3. Pfizer (XXL, US) ☀
Pharmaceuticals
3. Pfizer (XXL, US) ☀
Pharmaceuticals
97
35
72
91
4. Assertio Therapeutics (S, US) Pharmaceuticals
4. Assertio Therapeutics (S, US) Pharmaceuticals
95
77
25
89
5. Bristol-Myers Squibb (XXL, US) ☀
Pharmaceuticals
5. Bristol-Myers Squibb (XXL, US) ☀
Pharmaceuticals
83
61
27
71
6. Nektar (S, US) Pharmaceuticals
6. Nektar (S, US) Pharmaceuticals
27
51
89
70
7. Johnson & Johnson (XXL, US) ☀
Pharmaceuticals
7. Johnson & Johnson (XXL, US) ☀
Pharmaceuticals
35
59
69
58
December 8, 2022. Top 10s are published weekly by Top 10 schedule . (Free Stock Update )
☀ This company has a special achievement which is documented on its stock research page.
Top 10 lists may contain fewer than 10 stocks due to Obermatt’s top 10 quality standards .
Top 10 Stocks from the purely fact-based Obermatt Method in the stock index Dow Jones U.S. Pharmaceuticals Index from December 8, 2022.
Top 10 Stock History D.J. US Pharmaceutical
Select Top 10 Date
Dec‑2022
Apr‑2022
Aug‑2020
Mar‑2020
Oct‑2019
Apr‑2019
Nov‑2018
Jun‑2018
Oct‑2017
Apr‑2017
Jan‑2017
Jan‑2016
Jan‑2015